Non-coding RNA in vascular pathophysiology (renewal)
In plain English
AI plain-English summaryWhen blood vessels are damaged—by surgery, stents, or disease—the inner lining can thicken abnormally, narrowing the passage and restricting blood flow. This process, called neointima formation, is a major clinical problem after procedures like angioplasty or bypass grafting. The researchers have already shown that small pieces of genetic material called microRNAs (miRNAs) play a key role in this thickening. Now they want to understand exactly how these molecules control the behaviour of the two main cell types in blood vessel walls: smooth muscle cells and endothelial cells. They will use genetically modified mice to track what happens when miRNA production is disrupted, and they will also investigate a related class of molecules called long non-coding RNAs (lncRNAs). This is fundamental science—it does not aim to produce a new treatment tomorrow. But understanding the molecular wiring that drives vessel narrowing could eventually point to new drug targets for preventing restenosis (re-narrowing after treatment) or for managing conditions like atherosclerosis. Similar fundamental work on non-coding RNA has already led to clinical trials for cancer and heart disease, so the translational potential here is real, if distant.
View original technical description
View the original record at the funder ↗
Researchers
Related Research
Grants with similar aims, by meaning.
Original classification
Programme GrantPlain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research. Is something wrong? Let us know